Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
JCI Insight|March 7, 2023
Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell- and CXCR3-dependent mannerMichael Brandon Ware, Maggie Phillips, Christopher McQuinn, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2016
Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic AdenocarcinomaAnne M Noonan, Matthew R Farren, Susan M Geyer, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Physical Activity Delays Obesity-Associated Pancreatic Ductal Adenocarcinoma in Mice and Decreases InflammationValentina Pita-Grisanti, Kelly Dubay, Ali Lahooti, et al.
Journal of Cancer|June 22, 2026
Association between obesity, sex, medical comorbidities, and survival in cancer patients treated with immune checkpoint inhibitorsMingjia Li, Daniel J Spakowicz, Songzhu Zhao, et al.
Clinical Lung Cancer|February 8, 2022
Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not ChemoimmunotherapyYizhen Guo, Lai Wei, Sandip H Patel, et al.
Neoplasia (New York, N.Y.)|September 24, 2016
Stromal ETS2 Regulates Chemokine Production and Immune Cell Recruitment during Acinar-to-Ductal MetaplasiaJason R Pitarresi, Xin Liu, Sudarshana M Sharma, et al.
Frontiers in Immunology|January 2, 2026
Tumor intrinsic properties dictate Fc receptor expression and cancer cachexia associated increase in checkpoint inhibitor clearanceBryan C Remaily, Greg Young, Hannah Lathrop, et al.
Clinical and Translational Gastroenterology|January 29, 2024
Systemic Neutrophil Gelatinase-Associated Lipocalin Alterations in Chronic Pancreatitis: A Multicenter, Cross-Sectional StudyKristyn Gumpper-Fedus, Kaylin Chasser, Valentina Pita-Grisanti, et al.
Cancer Research|May 23, 2024
Physical Activity Decreases Inflammation and Delays the Development of Obesity-Associated Pancreatic Ductal AdenocarcinomaValentina Pita-Grisanti, Ericka Velez-Bonet, Kaylin Chasser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2015
The Raf Kinase Inhibitor Sorafenib Inhibits JAK-STAT Signal Transduction in Human Immune CellsSara E Martin del Campo, Kala M Levine, Bethany L Mundy-Bosse, et al.
Pageof 7